The present disclosure provides methods for treating a mammal that has endometriosis using a CHRH1 antagonist composition. In some embodiments, the CHRH1 antagonist is antalarmin or an equivalent.
University
University of Texas System
Assignee
The Board Of Regents Of The University Of Texas System